Health Ministry Reports on Lenacapavir Rollout
The Minister of Health answered a parliamentary question on lenacapavir uptake and the challenges of implementing the HIV prevention injection.
Updated on Nov. 11, 2026 in Sexual Health
South Africa's national launch of lenacapavir occurred on 05 June 2026, with Phase 1 access restricted to 360 public health facilities in 24 districts across six provinces. The Minister of Health addressed parliament on uptake and implementation challenges.
Why it matters
Lenacapavir is being rolled out as an HIV prevention option, and the phased, facility-restricted approach shapes who can access it during the early stage. Reported gaps in provincial data monitoring affect how completely the programme's uptake can be tracked.
Phase 1 covers 360 public health facilities in 24 districts across six provinces, and all 360 have healthcare providers trained on lenacapavir. The source does not report uptake figures, and Western Cape data cannot be broken down by gender and age because the province did not adopt the national monitoring system.
The players
Minister of Health
The national minister responsible for South Africa's public health policy, who answered the parliamentary question on lenacapavir implementation.
The details
Before starting or continuing lenacapavir, all clients must be confirmed HIV-negative. Facilities use appointment and SMS systems to help clients attend their continuation injections, and all public health facilities provide HIV testing services.
Timeline
05 June 2026: National launch of lenacapavir.
05 June 2026 to 14 October 2026: Reporting period for lenacapavir uptake data.
20 November 2026: First clients are due for continuation injections.
Big Picture
The lenacapavir launch extends South Africa's national HIV prevention rollout through public health facilities into a long-acting injectable option. Its phased, facility-restricted start follows the staged approach the national programme has used for new prevention tools.
Clients must test HIV-negative before each lenacapavir injection and attend scheduled continuation visits, which facilities support with appointment and SMS reminders. Access is currently limited to the 360 Phase 1 facilities, so people outside those sites may need to wait for later phases.
The takeaway
If you are considering lenacapavir, ask your nearest Phase 1 public health facility whether it is offering the injection and what the testing and continuation schedule involves. Keeping your continuation appointment is essential to staying protected.
What happens next
Clients are due for continuation injections from 20 November 2026 onwards, when the first follow-up doses fall due.
Further reading
For broader background, see Sexual Health coverage on HIV prevention in South Africa.
Source note: This article includes information reported by Pmg.
